.Attributes Medicine, Published online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec obtained FDA authorization after an unfavorable test, which highlights the many complexities and also obstacles of medicine growth in this particular environment.